Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

The US Food and Drug Administration has approved the use of the drug tucatinib, or Tukysa, in combination with chemotherapy, for the treatment of adults with advanced forms of HER2-positive breast ...

AI-driven Clairity Breast platform, now FDA-approved, predicts five-year breast cancer risk from mammograms, enhancing early ...

Fourteen cancer drugs are in shortage, according to the Food and Drug Administration. IE 11 is not supported. For an optimal experience visit our site on another browser.

Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short.

ANNAPOLIS, Md. (7News) — Fourteen cancer treatment drugs are in short supply, according to the Food and Drug Administration, adding to a growing list of medications either unavailable, back ...

U.S. Food and Drug Administration. Add Topic. First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the agency's website, as the Trump administration halts DEI initiatives.

FDA debates ban on Red Dye No. 3 amid cancer concerns 04:37. The Food and Drug Administration announced Wednesday it had decided to revoke Red 3's authorization to be added to foods, over concerns ...